GET DAILY SIGNALSSuperior Group of Companies (SGC) Posts +5% Sales Growth in Q3 as Diversified Segments Offset Apparel Pressures
Key Takeaways
- Consolidated net sales rose 5% year over year to $146.0 million in the third quarter, accelerating from the 3% growth reported in the second quarter.
- Diluted earnings per share (EPS) came in at $0.17, down slightly from $0.18 a year earlier, while net income was $2.6 million.
- Branded Products revenue grew 8% and Contact Centers grew 7%, but a 3% decline in Healthcare Apparel and a $4 million inventory write-down weighed on profitability.
- EBITDA was $6.7 million, down from $7.5 million in the prior-year period.
- Management tightened full-year 2026 guidance to net sales of $578–$585 million and adjusted EPS of $0.60–$0.66.
- The acquisition of Select VoiceCom, a Philippine business process outsourcing (BPO) provider, closed and is expected to be accretive to earnings in the first quarter of 2027.
Why This Quarter Matters
Superior Group of Companies (SGC) runs three distinct businesses—Branded Products, Healthcare Apparel, and Contact Centers—which provides a useful window into consumer, healthcare, and business-services demand. The third quarter sits at the midpoint of the company’s “back-end weighted” 2026 plan, so investors are paying close attention to whether the diversified portfolio can offset the ongoing repositioning in Healthcare Apparel. That segment has seen inventory write-downs in consecutive quarters. The report also arrives right after the closing of the Select VoiceCom acquisition, which management views as a way to expand the Contact Centers segment into offshore delivery. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The Numbers Breakdown
For the third quarter ended September 30, 2026, SGC reported consolidated net sales of $146.0 million, up 5% from $138.5 million in the prior-year quarter. Net income was $2.6 million, or $0.17 per diluted share, compared with $2.7 million, or $0.18 per diluted share, a year earlier. The company topped revenue expectations while falling slightly short on EPS.
Gross margin held at 38%, roughly flat both year over year and sequentially. Branded Products led the quarter with 8% revenue growth to $92 million, supported by higher volumes from existing customers and new customer additions; its gross margin improved 160 basis points and EBITDA rose 31%. Contact Centers grew revenue 7% to $24 million, with EBITDA up 22%. Healthcare Apparel revenue declined 3% to $31 million, and its gross margin fell 580 basis points due to a $4 million inventory write-down tied to streamlining the product assortment, partially offset by $1.8 million in tariff refunds. The segment also recorded a credit-loss charge of about $1 million related to a customer’s financial position.
Management tightened its full-year 2026 outlook to net sales of $578 million to $585 million (from $572 million to $585 million) and adjusted diluted EPS of $0.60 to $0.66 (from $0.54 to $0.66), up from $0.46 in 2025.
Market Reaction and Sentiment
Investor reaction reflected the contrast between accelerating top-line growth and lingering margin pressure in Healthcare Apparel. While Branded Products and Contact Centers delivered double-digit EBITDA growth, the $4 million inventory write-down and roughly $1 million credit-loss charge in Healthcare Apparel pulled consolidated EBITDA below the prior-year level and left diluted EPS slightly lower year over year. The tightening of full-year guidance, including a raised floor on both revenue and adjusted EPS, signals management’s confidence in the underlying business. From what I see, sentiment around the stock is also being shaped by the company’s disclosure that Healthcare Apparel margin pressure is expected to persist into the first half of 2027 as it discounts inventory to complete its assortment reset.
Forward Outlook and Key Factors to Monitor
Looking ahead, investors are likely to focus on whether the Healthcare Apparel repositioning begins to translate into higher margins and lower working-capital needs. Management has indicated the most challenging phase of the inventory work is largely complete, but continued discounting is expected to pressure segment margins into the first half of 2027. The pace of that recovery will be a central theme over the next several quarters.
Separately, the integration of Select VoiceCom will be closely watched. The acquisition adds an established offshore operation in the Philippines and is expected to be accretive in the first quarter of 2027, its first full quarter under SGC ownership. Management plans to provide additional pro forma financial details in its annual filing and to fold the acquisition into 2027 guidance during the fourth-quarter earnings call.
Finally, Branded Products remains the company’s growth engine, with new sales and marketing leadership investments aimed at sustaining mid-to-upper single-digit growth and advancing management’s long-term goal of reaching $1 billion in revenue. Tariff developments, input-cost trends, and the broader macroeconomic backdrop will continue to influence order patterns across all three segments. I’m watching this closely as the company moves into 2027.
Using Tickeron’s AI Tools for Research
In my analysis of SGC and similar names, I often turn to Tickeron’s AI Screener to quickly filter stocks by industry, technical patterns, and fundamentals. It helps surface relevant comparisons and trade ideas without spending hours on manual screens. The tool has become a regular part of how I review earnings movers and broader sector setups.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Aroon Indicator for SGC shows an upward move is likely
SGC's Aroon Indicator triggered a bullish signal on October 27, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 209 similar instances where the Aroon Indicator showed a similar pattern. In 179 of the 209 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on SGC as a result. In 87 of 112 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for SGC just turned positive on November 04, 2026. Looking at past instances where SGC's MACD turned positive, the stock continued to rise in 37 of 52 cases over the following month. The odds of a continued upward trend are 71%.
SGC moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where SGC advanced for three days, in 190 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 49 cases where SGC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
SGC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. SGC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.108) is normal, around the industry mean (2.911). P/E Ratio (24.000) is within average values for comparable stocks, (14.016). Projected Growth (PEG Ratio) (1.418) is also within normal values, averaging (0.686). Dividend Yield (0.042) settles around the average of (0.328) among similar stocks. P/S Ratio (0.326) is also within normal values, averaging (0.827).
The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of employee uniforms, image apparel, scrubs and patient apparel
Industry ApparelFootwear
Advertisement